Suvorexant May Ease Symptoms During Opioid Withdrawal Therapy

TUESDAY, July 12, 2022 -- For individuals with opioid use disorder undergoing a buprenorphine/naloxone taper, suvorexant might be a promising treatment for reducing sleep disturbance and easing opioid withdrawal, according to a study published...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news